Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Single-cell transcriptomic analysis following CRISPR/Cas9 knockdown demonstrates a novel role for human T cell-intrinsic IL-1β in determining T cell metabolic landscape.

Created on 18 Nov 2026

Authors

Kshitija Kale, Chakrapani Vemulawada, Kai J Rogers, Michael P Crawford, Jace Heath, Nitin J Karandikar

Published in

ImmunoHorizons. Volume 10. Issue 11. Nov 05, 2026.

Abstract

T helper 17 (Th17) CD4+ T cells are key mediators of autoimmune pathology. Interleukin (IL)-1β is a potent proinflammatory cytokine known to promote Th17 differentiation and pathogenicity, in combination with other cytokines. Whereas recent studies have shown that T cells are capable of expressing IL-1β themselves, the role of this T cell-endogenous IL-1β is poorly understood. Using CRISPR/Cas9-mediated deletion of IL1B in naïve human CD4+ T cells along with cytokine neutralization and IL-1 receptor blockade, we found that T cell-intrinsic IL-1β is not essential for Th17 differentiation or effector resistance. Remarkably, single-cell RNA sequencing revealed that IL1B deletion profoundly rewires the transcriptional and metabolic landscape within the T cells, suppressing glycolytic and hypoxia-responsive pathways. These findings uncouple T cell-intrinsic IL-1β from Th17 effector resistance while uncovering an important contribution toward sustaining metabolic roles. This refines our understanding of IL-1β biology and informs therapeutic strategies in immune-mediated disease settings.

PMID:
43043978
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement